1 Department of Neurosurgery and Department of Clinical Epidemiology and Medical Technology Assessment, Academic Hospital Maastricht; Department of Health Sciences, University of Maastricht, The Netherlands; and Centre for Movement Disorders, St. Lucas Hospital, Ghent, Belgium
Object. The aim of this study was to evaluate the long-term effects of unilateral pallidal stimulation on motor function in selected patients with advanced Parkinson disease (PD).
Methods. The authors enrolled 26 patients with idiopathic PD in whom there was an asymmetric distribution of symptoms and, despite optimal pharmocological treatment, severe response fluctuations and/or dyskinesias. After the patient had received a local anesthetic agent, a quadripolar electrode (Medtronic model 3387) was implanted at the side opposite the side affected or, if both sides were affected, the side contralateral to the more affected side. No serious complications occurred. After 3 months, the total Unified PD Rating Scale (UPDRS) Part III score decreased by 50.7% while patients were in the off-medication state (from 26.5 ± 9.2 to 13.1 ± 6.1) and by 55.4% while they were in the on-medication state (from 10.6 ± 6.3 to 4.7 ± 4.4). Only during the on state was the contralateral effect clearly more pronounced. The UPDRS Part IVa score decreased by 75% (from 3.7 ± 2.5 to 0.9 ± 1.1) and the UPDRS Part IVb score by 54.7% (from 3.3 ± 1.3 to 1.5 ± 1.3).
At long-term follow-up review (32.7 ± 10.7 months), there was an 8.3% increase in the UPDRS Part III score while patients were in the off state (from 26.5 ± 9.2 to 28.7 ± 7.6) and a 40.2% increase in this score while patients were in the on state (from 10.6 ± 6.3 to 14.9 ± 5.1). The UPDRS Part IVa score decreased by 28.1% (from 3.7 ± 2.5 to 2.7 ± 2.3) and the UPDRS Part IVb score increased by 3.5% (from 3.3 ± 1.3 to 3.4 ± 1.6).
Conclusions. Based on these unsatisfactory results at long-term review, the authors conclude that unilateral pallidal stimulation is not an effective treatment option for patients with advanced PD.
The Deep-Brain Stimulation for Parkinson's Disease Study Group:Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease.N Engl J Med345:956–9632001The Deep-Brain Stimulation for Parkinson's Disease Study Group:
Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 345:
FahnSEltonRLMembers of the UPDRS Development Committee: Unified Parkinson's Disease Rating ScaleFahnSMarsdenCDGoldsteinMet al (eds): Recent Developments in Parkinson's Disease.Florham Park, NJ: Macmillan Healthcare Information19872153––163Recent Developments in Parkinson's Disease.
MerelloM: Subthalamic stimulation contralateral to a previous pallidotomy: an erroneous indication?Mov Dis14:8901999(Letter)Merello M: Subthalamic stimulation contralateral to a previous pallidotomy: an erroneous indication? Mov Dis 14:
MoringlaneJRCeballos-BaumannAOAleschF: Long-term effect of electrostimulation of the subthalamic nucleus in bradykinetic-rigid Parkinson's disease.Minim Invasive Neurosurg41:133–1361998Minim Invasive Neurosurg 41:
SiegfriedJLippitzB: Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms.Neurosurgery35:1126–11301994Neurosurgery 35:
van der LindenCVandewalleVColleHet al: Chronic bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease: a long-term follow up in 39 patients.Mov Disord15(Suppl 3):62–632000(Abstract)Mov Disord 15 (Suppl 3):